Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 3:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1297–1320 of 8,267 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: SPD489; Drug
Lead sponsor: Shire; Industry
Eligibility: 4 Years to 5 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 6
States / cities: Newport Beach, California • Baltimore, Maryland • Las Vegas, Nevada + 3 more

Conditions: Epilepsy
Interventions: Eslicarbazepine acetate; Drug
Lead sponsor: Sumitomo Pharma America, Inc.; Industry
Eligibility: 4 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Henderson, Nevada

Conditions: Head and Neck Cancer
Interventions: Cetuximab, 50-60 Gy and 70 Gy; Drug · Radiation
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 70 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2020
U.S. locations: 2
States / cities: Ann Arbor, Michigan

Conditions: Mixed Hearing Loss, Single-Sided Deafness, Conductive Hearing Loss
Interventions: Osia 2 System; Device
Lead sponsor: Cochlear; Industry
Eligibility: 5 Years to 11 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Phoenix, Arizona • Palo Alto, California • San Diego, California + 4 more

Conditions: Rheumatoid Arthritis, Healthy Controls
Interventions: Blood Draw, Disease Activity (DAS-28) Assessment, Skeletal Muscle Mitochondrial Respiratory Capacity, Muscle Biopsy, Body Composition, Cardiopulmonary Exercise Test (CPET), Strength Testing, Questionnaires, Skeletal Muscle Biomechanical Property Assessment; Other
Lead sponsor: Duke University; Other
Eligibility: 25 Years to 75 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Alzheimer Disease
Interventions: transcranial alternating current stimulation (tACS); Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 21 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Age-Related Macular Degeneration
Interventions: DE-120, Aflibercept; Drug
Lead sponsor: Santen Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 14
States / cities: Phoenix, Arizona • Bakersfield, California • Walnut Creek, California + 11 more

Conditions: Cardiac Output, Blood Pressure
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Transplant and Cell Therapy
Interventions: Social Determinants of Health Questionnaire; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Measles, Measles-Mumps-Rubella+Chickenpox Vaccine
Interventions: MMRVNS, MMRV; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 15 Months to 6 Years
Enrollment: 1,209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 17
States / cities: Birmingham, Alabama • Walnut Creek, California • Miami, Florida + 12 more

Conditions: Autism Spectrum Disorder
Interventions: SDARI-YA, AYA; Behavioral · Other
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Influenza
Interventions: CAIV-T, TIV; Biological · Other
Lead sponsor: MedImmune LLC; Industry
Eligibility: 6 Months to 36 Months
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 5
States / cities: Layton, Utah • Ogden, Utah • Pleasant Grove, Utah + 2 more

Conditions: Healthy Volunteer
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Focal Seizures
Interventions: CBD-OS; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 12 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 24
States / cities: Phoenix, Arizona • La Jolla, California • New Haven, Connecticut + 20 more

Conditions: Nutritional Deficiencies
Interventions: Meat, Cereal, fortified rice cereal; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 6 Months to 18 Months
Enrollment: 1,488 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Preterm Birth, Short Cervical Length
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 4
States / cities: Indianapolis, Indiana • Pittsburgh, Pennsylvania • Galveston, Texas + 1 more

Conditions: Dysphagia
Interventions: Thickenup, Thickenup Advance; Dietary Supplement
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Diabetes
Interventions: Reciprocal Diabetes Peer Support Program, Nurse Case management, group outpatient counseling visits; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diabetic Retinopathy
Interventions: Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears, Aqueous PGE2 and inflammatory cytokines measurements; Drug · Other
Lead sponsor: Stephen J. Kim, MD; Other
Eligibility: 18 Years and older
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obesity, Small for Gestational Age
Interventions: Not listed
Lead sponsor: Oklahoma State University Center for Health Sciences; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Attention Deficit and Disruptive Behavior Disorders, Attention Deficit Hyperactivity Disorder, Child, Preschool, Sleep, Sleep Disturbance
Interventions: Brief Parent Behavioral Intervention, Sleep-Focused Parent Behavioral Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 3 Years to 5 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Cranberry Township, Pennsylvania • Monroeville, Pennsylvania • New Castle, Pennsylvania + 1 more

Conditions: Muscle Relaxants
Interventions: Not listed
Lead sponsor: Shashi Bhatt, MD; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: High Risk Acute Myeloid Leukemia
Interventions: CPX-351, 7+3 (cytarabine and daunorubicin); Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 60 Years to 75 Years
Enrollment: 309 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 39
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 31 more

Conditions: Anesthesia Intubation Complication
Interventions: propofol; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 1 Year to 11 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Charlottesville, Virginia

Search by objective public record fields.

Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity Disorder

A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug

Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)

Osia 2 Pediatric Expansion Study

MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics

Memory Functions in Mild Alzheimer's Disease

A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Cardiac Function as Measured by Non-invasive Electrical Velocimetry Cardiac Monitor in Hospitalized Children

Prospective Observational Cohort Study of Transplant and Cell Therapy Candidates and Recipients to Assess Social Determinants of Health

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

Social Groups for Autistic Young Adults (SDARIYA)

Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)

Visual Attention, Object Recognition, and Eye Movements in Healthy Volunteers

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

Development and Health of Rural Chinese Children Fed Meat as a Daily Complementary Food From 6-18 Mos of Age

The Impact of Vaginal and IM Progestins on the Cervix

Evaluation of Two Different Thickening Products in Patients With Dysphagia

Improving Insulin Therapy With Enhanced Care Management

INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study

Maternal Obesity and Small for Gestational Age Infants

Optimizing Attention and Sleep Intervention Study

The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine

Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia

Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction